Vimarsana
Biggest News Aggregation in the World

Page 3 - Thomas Eldered News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Eldered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Eldered Today - Breaking & Trending Today

Bought a tablet factory – and built his own empire - Vimarsana News

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move its production abroad. 34-year-old Thomas was facing an imminent risk of losing his job. However, instead, it actually turned out to be the starting point for one of the biggest success stories in Swedish life science.

NorthX Biologics appoints industry veterans to its board of directors - Vimarsana News

NorthX Biologics appoints industry veterans to its board of directors

NorthX Biologics appoints industry veterans to its board of directors - read this article along with other careers information, tips and advice on BioSpace

XNK Therapeutics AB: XNK Therapeutics raises SEK 132 million to accelerate growth - Vimarsana News

XNK Therapeutics AB: XNK Therapeutics raises SEK 132 million to accelerate growth

STOCKHOLM, March 29, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie Invest

XNK Therapeutics raises SEK 132 million to accelerate growth - Vimarsana News

XNK Therapeutics raises SEK 132 million to accelerate growth

/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie...

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform - Vimarsana News

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform

/PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted personalized...